American Association of Clinical Endocrinologists and American College of Endocrinology: clinical practice guidelines for developing a diabetes mellitus comprehensive care plan 2015
In practice, these doctors almost certainly will not have prescribed either agent, unless they have prescribed them privately
That study enrolled 3,417 adults with obesity or overweight and without type 2 diabetes, and showed a mean weight loss of 22.7% at 68 weeks in patients who remained on treatment
100 Americans died because of heart problems
Originally developed as diabetes medications, new glucagon-like peptide-1 (GLP-1) medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) suppress a patients appetite, slow gastric emptying, and help the pancreas increase its production of insulin to regulate blood sugar
Youre a good candidate for this treatment if you: Patients with a personal or family history of medullary thyroid carcinoma or MEN2, active pancreatitis, or allergy to the medication are generally NOT candidates